Evidence map›Paper›PMID 36961607›Full record

ArticleSurgery today2023

The surgical Apgar score predicts postoperative complications and the survival in lung cancer patients.

Haruaki Hino, Satoshi Hagihira, Natsumi Maru, Takahiro Utsumi, Hiroshi Matsui, Yohei Taniguchi, Tomohito Saito, Tomohiro Murakawa

Abstract read
PubMed Publisher
In one paragraph

Article in Surgery today, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Haruaki HinoDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan. hinoh@hirakata.kmu.ac.jp.
Satoshi HagihiraDepartment of Anesthesiology, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Natsumi MaruDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Takahiro UtsumiDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Hiroshi MatsuiDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Yohei TaniguchiDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Tomohito SaitoDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Tomohiro MurakawaDepartment of Thoracic Surgery, Kansai Medical University, 2-5-1 Shinmachi Hirakata-Shi, Osaka, 573-1191, Japan.
Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe surgical Apgar score (SAS)-calculated using the intraoperative variables estimated blood loss, lowest heart rate, and lowest mean systolic pressure-is associated with mortality in cancer surgery. We investigated the utility of the SAS in patients with lung cancer undergoing surgery.

methodsWe retrospectively analyzed the data of 691 patients who underwent surgery for primary lung cancer between 2015 and 2019 in a single institute and analyzed the impact of the SAS.

resultsOf the 691 patients, 138 (20%), 57 (8.2%), and 7 (1.0%) had postoperative complications of all grades, grades ≥ III, and grade V, respectively, according to the Clavien-Dindo classification. The C-index for postoperative complications of grades ≥ III was 0.605. A lower score (0-5 points) (odds ratio 3.09 against 8-10 points, P = 0.04) and a lower percentage of vital capacity (odds ratio 0.97, P = 0.04) were independent negative risk factors for major postoperative complications. Patients with a lower score (0-5 points) had poor 5-year overall and cancer-specific survival rates (60.1% and 72.3%, respectively; P < 0.05 for both).

conclusionsThe surgical Apgar score predicted postoperative complications and the long-term survival. Surgeons may improve surgical results using the SAS.

Indexed as

Lung NeoplasmsPostoperative ComplicationsApgar ScoreBlood Loss, SurgicalHumansInfant, NewbornRetrospective StudiesLung cancer surgeryPostoperative outcomesPrognostic markerSurgical Apgar score

Identifiers

PMID36961607
OpenAlexW4360803777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.